4-MPD Stats & Data

4‑MPD is the para‑methyl analogue of pentedrone and a higher homologue of mephedrone; like many synthetic cathinones, effects are short‑lived, encouraging redosing. Acute risks include tachycardia, hypertension, hyperthermia, anxiety, and peripheral vasoconstriction; these mirror the sympathomimetic toxicity profile seen with other stimulants. Monitor vitals; stop and cool if temperature rises or if resting HR >120 bpm or BP >140/90 while seated. Avoid polydrug use with MAOIs, serotonergic cough syrups (DXM), or seizure‑threshold‑lowering agents (e.g., bupropion, tramadol). Compulsive administration and binges are widely reported with short‑acting cathinones; set a pre‑commitment plan (total session limit, dose cap, no overnight use) and adhere to minimum 60–90 min redose gaps. Oral dosing is generally safer than vaping or insufflation; if snorting, crush finely, use your own sterile straw, and rinse nose before/after to reduce septal injury. Maintain hydration and electrolytes but avoid overhydration; sip ~250 mL/h when active in hot settings and take cooling breaks. Because supply is unregulated and mis‑selling is common, use professional drug‑checking where available; reagent tests are only preliminary. Avoid use if you have cardiovascular disease, uncontrolled hypertension, hyperthyroidism, or a history of stimulant‑induced psychosis; seek medical help for chest pain, severe headache, confusion, or persistent hyperthermia. Storage: keep dry, cool, and airtight; aqueous solutions of β‑keto compounds can degrade over time. Post‑use low mood, fatigue, and sleep disruption are common; allow multi‑day recovery, nutrition, and sleep; avoid chasing the comedown with depressants.